Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,663
+$71,437 QoQ
Shares Held
239
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#4,194
of 4,605 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantum Portfolio Management LLC holds $3,261,987 across 8 Drug Manufacturers - General names. LLY ranks #6 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,125 | $793,656 | |
| 2 | AZN |
Astrazeneca PLC
|
3,012 | $571,135 | |
| 3 | NVS |
Novartis AG
|
3,206 | $502,443 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,618 | $457,098 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,465 | $316,752 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
239 | $286,663 | |
| 7 | ABBV |
AbbVie Inc.
|
744 | $187,220 | |
| 8 | AMGN |
Amgen Inc
|
406 | $147,020 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,663 | 239 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $215,226 | 234 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $234,280 | 218 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $232,715 | 305 | Shares | Sole | 2025-10-29 | |
| 2024-12-31 | $213,844 | 277 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $262,238 | 296 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $229,061 | 253 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $663,599 | 853 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $516,467 | 886 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||